RLT Roundtables
The challenges of patient management and access to care are explored in the sixth part of our RLT roundtable discussion.
The fifth segment of the RLT roundtable explores recent clinical trials, including the VISION study.
The fourth part of this roundtable delves into the VISION and PSMAfore studies and their implications.
The third part of this roundtable explores imaging interpretation and toxicity management.
An expert panel discusses the evolving landscape of radioligand therapy for prostate cancer.
The panel discusses the role of PSMA imaging in prostate cancer, theranostics, and radioligand therapy.
Advertisement
Advertisement
© 2024 Mashup Media, LLC, a Formedics Property. All Rights Reserved.